These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 22342866)
1. A multi-centre analysis of the impact of updated risk stratification on follow-up of gastric gastro-intestinal stromal tumours in the post-imatinib era. Reece-Smith AM; MacGoey P; Shah MA; Leeder P; Andrew DR; McCulloch T; Parsons SL Eur J Surg Oncol; 2012 Jun; 38(6):484-9. PubMed ID: 22342866 [TBL] [Abstract][Full Text] [Related]
2. Six months neoadjuvant imatinib improves resectability potential of gastric stromal tumors in Egyptian patients. Saied GM; Kensarah AM Int J Surg; 2010; 8(2):105-8. PubMed ID: 19944196 [TBL] [Abstract][Full Text] [Related]
3. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes. Rutkowski P; Bylina E; Wozniak A; Nowecki ZI; Osuch C; Matlok M; Switaj T; Michej W; Wroński M; Głuszek S; Kroc J; Nasierowska-Guttmejer A; Joensuu H Eur J Surg Oncol; 2011 Oct; 37(10):890-6. PubMed ID: 21737227 [TBL] [Abstract][Full Text] [Related]
4. Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease. An JY; Choi MG; Noh JH; Sohn TS; Kang WK; Park CK; Kim S Eur J Surg Oncol; 2007 Oct; 33(8):1030-5. PubMed ID: 17428635 [TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib. Tielen R; Verhoef C; van Coevorden F; Gelderblom H; Sleijfer S; Hartgrink HH; Bonenkamp JJ; van der Graaf WT; de Wilt JH Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087 [TBL] [Abstract][Full Text] [Related]
6. Surgical management of rectal gastrointestinal stromal tumors. Tielen R; Verhoef C; van Coevorden F; Reyners AK; van der Graaf WT; Bonenkamp JJ; van Etten B; de Wilt JH J Surg Oncol; 2013 Mar; 107(4):320-3. PubMed ID: 22806955 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant imatinib treatment after R0 resection for patients with high-risk gastrointestinal stromal tumors: a median follow-up of 44 months. Jiang WZ; Guan GX; Lu HS; Yang YH; Kang DY; Huang HG J Surg Oncol; 2011 Dec; 104(7):760-4. PubMed ID: 21713778 [TBL] [Abstract][Full Text] [Related]
9. Management of localized gastrointestinal stromal tumors and adjuvant therapy with imatinib. López RL; del Muro XG Anticancer Drugs; 2012 Jun; 23 Suppl():S3-6. PubMed ID: 22739667 [TBL] [Abstract][Full Text] [Related]
10. The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour. Machlenkin S; Pinsk I; Tulchinsky H; Ziv Y; Sayfan J; Duek D; Rabau M; Walfisch S Colorectal Dis; 2011 Oct; 13(10):1110-5. PubMed ID: 21040362 [TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib. Jakob J; Mussi C; Ronellenfitsch U; Wardelmann E; Negri T; Gronchi A; Hohenberger P Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573 [TBL] [Abstract][Full Text] [Related]
12. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables. Rossi S; Miceli R; Messerini L; Bearzi I; Mazzoleni G; Capella C; Arrigoni G; Sonzogni A; Sidoni A; Toffolatti L; Laurino L; Mariani L; Vinaccia V; Gnocchi C; Gronchi A; Casali PG; Dei Tos AP Am J Surg Pathol; 2011 Nov; 35(11):1646-56. PubMed ID: 21997685 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of adjuvant post-surgical therapy with imatinib in gastrointestinal stromal tumor patients with high risk of recurrence: interim analysis from a multicenter prospective clinical trial]. Zhan WH; Wang PZ; Shao YF; Wu XT; Gu J; Li R; Wan DS; Ding KF; Shi YQ; Yu JR; Lu HS; Zou XM; Bi JW; Sun YH; Lu YF; Chen DD; Zhang XH Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):383-7. PubMed ID: 17043955 [TBL] [Abstract][Full Text] [Related]
14. Choices of surgical approaches for gastrointestinal stromal tumors of the stomach: laparoscopic versus open resection. Wan P; Yan C; Li C; Yan M; Zhu ZG Dig Surg; 2012; 29(3):243-50. PubMed ID: 22846475 [TBL] [Abstract][Full Text] [Related]
15. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease. Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358 [TBL] [Abstract][Full Text] [Related]
16. [How should patients with completely resected gastrointestinal stromal tumours (GIST) be followed up?]. Stelzner S; Antoni C; Haroske G; Jacobasch L; Erk JU; Ludwig K Zentralbl Chir; 2005 Dec; 130(6):554-61. PubMed ID: 16382404 [TBL] [Abstract][Full Text] [Related]
17. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate. Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131 [TBL] [Abstract][Full Text] [Related]
18. Recurrence risk after resection of gastrointestinal stromal tumors: size is not all that matters... The consequences of tumor rupture. Han D; Deneve J; Gonzalez RJ Am Surg; 2012 Jan; 78(1):74-9. PubMed ID: 22273319 [TBL] [Abstract][Full Text] [Related]